Intellectual Property and Transfer of Innovation in Biotechnology

  • Cristina Popa
  • Narcisa Elena Babeanu
  • Ovidiu Popa


Intellectual property biotechnology, with special emphasis on biotech patents, is considered a strong tool in the development of biotechnological R&D and biotech industry. In the European patent system, more than 50% of the granted biotech patents cover pharmaceutical products, around 40% refer to industrial processes in biotechnology, and the rest are patents granted for application of biotechnology in agriculture and environmental protection.

The authors propose to reveal specific insights into patenting biotechnological inventions, according to the European Patent System, emphasizing what can be protected or not protected by patents in the area of biotechnology, considering the legislation in force in this field, and ethical and moral disputes on this subject.

The authors give special attention to aspects regarding the transfer of innovation in biotechnology, referring to its very specific problems and how intellectual property could interfere with facilitating this transfer of knowledge.


Intellectual property Biotech patents Transfer of innovation 

List of Abbreviations


Board of appeal


Enlarged board of appeal


European Commission


European Patent Convention


European Patent Office


European Union


Decision of the EBoA


Guidelines for examination under the European Patent Convention


Intellectual property


Intellectual property right


Organization for Economic Cooperation and Development


Supplementary protection certificate


Decision of the technical board of appeal


Union pour la Protection des Obtentions Vegetales


World Intellectual Property Organization


  1. Arundel A (2003) Biotechnology indicators and public policy. STI Working Papers. OECD, ParisGoogle Scholar
  2. Blatmann A, Heuzenroeder P, O’Brien M (2008) Biotechnology intellectual property management manual. Spruson & Ferguson, pp 8–14Google Scholar
  3. Burrone E (2006) Patents at the core: the biotech business.
  4. DaSilva JE (2004) The colours of biotechnology: science, development and humankind. Electron J Biotechnol 7(3)Google Scholar
  5. Directive 98/44/EC (1998) Directive of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, published in Official Journal of the European Communities, 30 July 1998, extracted from
  6. Dutfield G (2009) Intellectual property rights and the life science industries – past, present and future, 2nd edn. World Scientific, Singapore, pp 204–205CrossRefGoogle Scholar
  7. EC (2002) Life sciences and biotechnology – a strategy for EuropeGoogle Scholar
  8. EPC (2016a) European Patent Convention 2000, 16th edn, Chapter V, Rule 26, Biotechnological inventions, published on June 2016 on
  9. EPC (2016b) European Patent Convention 2000, 16th edn, Art. 64 (1), (3), published on June 2016 on
  10. EPC (2016c) European Patent Convention 2000, 16th edn, Art. 52–53, published on June 2016 on
  11. EPC (2016d) European Patent Convention 2000, 16th edn, Rule 29, published on June 2016 on
  12. EPC (2016e) European Patent Convention 2000, 16th edn, Art. 54(4) and (5), published on June 2016 on
  13. EPO (2009) Decision of the enlarged board of appeal G2/06, dated 25 November 2008, published in the Official Journal of the EPO 5/2009, p 306Google Scholar
  14. EPO (2012) Decisions of the enlarged board of appeal G2/07 and G1/08, dated 09.12.2010, published in the Official Journal of the EPO 3/2012, p 130, 206Google Scholar
  15. EPO (2016) Decisions of the enlarged board of appeal G2/12 and G2/13, dated 25 March 2015, published in the Official Journal of the EPO 2016, A27, A28Google Scholar
  16. EPO (2017a) Biotechnology patents at the EPO, extracted from, last updated on 16 January 2017
  17. EPO (2017b) Decision of the Administrative Council of 29 June 2017 amending rules 27 and 28 of the implementing regulations to the European Patent Convention (CA/D 6/17), Official Journal of the EPO, A56Google Scholar
  18. EPO (2017c) Is it in my genes? The future of personalised medicine is focused on individual patient DNA, last updated on 24 May 2017, from
  19. EPO (2017d) Using red algae to fight the flu, EPO SME case studies/MARINOMED, published on
  20. EPO (2018a) Annual report 2017 – European patent applications, published on 22 January 2018 on
  21. EPO (2018b) Decision of the opposition division of the EPO published in the European Patent Bulletin 8/44 of 29 October 2018Google Scholar
  22. EPO (2018c) Annual report 2017 – At a glance, published on 22 January 2018,
  23. EPO (2019) Decisions of the technical board of appeal T1063/18, issued on 05 February 2019, extracted from
  24. EU Commission (2016) Notice on certain articles of Directive 98/44/EC of the European Parliament and of the Council on the legal protection of biotechnological inventions, (2016/C 411/03). Off J Eur Union, C411/3, 08 November 2016Google Scholar
  25. EU Commission (2019) Protection of biotechnological inventions, extracted from Accessed January 2019
  26. Gelinas P (2010) Mapping early patents on baker’s yeast manufacture. Compr Rev Food Sci Food Saf 9:483–497CrossRefGoogle Scholar
  27. Guidelines for Examination (2018) GII-35.
  28. McNamara K, Booth M (2018) The birth of biotech, extracted from
  29. OECD (2002) Genetic inventions, IPRs and Licensing PracticesGoogle Scholar
  30. OECD (2004) Patents and innovation: trends and policy challengesGoogle Scholar
  31. OECD (2005) A framework for biotechnology statistics. OECD, ParisGoogle Scholar
  32. Ovlisen M (2002) In Medicon valley patent guide.
  33. Saez C (2017) Patentability of some biotech uncertain in Europe as examination, opposition suspended. Intellectual Property Watch.
  34. Singh KK (2015) Biotechnology and intellectual property rights – legal and social implications. Springer India, pp 66–67Google Scholar
  35. Strenc AC, Ionescu B, Gheorghiu G (2005) Dreptul Brevetului. Editura Lumina Lex, Bucuresti, pp 55–56Google Scholar
  36. Venter C, Cohen D (2004) The century of biology. N Perspect Q 21(4):73–77CrossRefGoogle Scholar
  37. WIPO Convention (1967) Convention establishing the world intellectual property organization, Art 2(vii)Google Scholar
  38. Zekos GI (2006) Nanotechnology and biotechnology patents. Int J Law Inform Technol 14:310CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Cristina Popa
    • 1
  • Narcisa Elena Babeanu
    • 2
  • Ovidiu Popa
    • 2
  1. 1.Rominvent SABucharestRomania
  2. 2.Faculty of BiotechnologiesUSAMVBBucharestRomania

Personalised recommendations